Loading…
for educational and safety purposes
Pramipexole and Ropinirole both come up in the same conversations; they overlap on dopamine D2/D3 receptors. Pramipexole: Pramipexole is a non-ergoline dopamine agonist used mainly to treat Parkinson's disease and restless legs syndrome. Ropinirole: Ropinirole is a non-ergoline dopamine agonist, a drug that mimics the action of dopamine at its receptors in the brain.
Pramipexole is a non-ergoline dopamine agonist used mainly to treat Parkinson's disease and restless legs syndrome. It works by directly stimulating dopamine receptors in the brain, with a preference for the D3 subtype, standing in for the dopamine signalling that is lost in Parkinson's disease. First approved in the United States in 1997 and sold under names such as Mirapex, Mirapexin and Sifrol, it is available as immediate-release and extended-release tablets and has also been studied off-label for depression.
Ropinirole is a non-ergoline dopamine agonist, a drug that mimics the action of dopamine at its receptors in the brain. It is used mainly to treat Parkinson's disease and moderate to severe restless legs syndrome. Taken by mouth, it is sold under brand names such as Requip.
both fingerprints on one instrument; where the marks line up the two compounds work the same lever, where a slot goes dark only one of them touches it. read straight from each entry's affinity table; nothing here is invented.
agonist
agonist
agonist
agonist
activates
activates
agonist
agonist
agonist
agonist
strengths are the entries' qualitative ratings (strong / moderate / weak); Ki and EC50 figures appear where an entry records them.
easiest to source: Pramipexole is currently listed by more trusted vendors (2), so it's the simpler one to get hold of. for effects and safety, read each full entry; this is educational, not medical advice.